Patients with cancer are at increased risk for thrombosis, and those with thrombi have poorer overall survival rates than those without. In a new review article, Dr. Jean Connors from Brigham and Women’s Hospital and Dana Farber Cancer Institute summarizes available data and provides guidance for determining which patients might benefit from thromboprophylaxis. The incidence of… Read More…
Posts Tagged ‘thromboprophylaxis’
Prophylaxis against Venous Thromboembolism in Ambulatory Cancer Patients
Posted by Sara Fazio • June 27th, 2014
Low-Molecular-Weight Heparin in Medical Patients
Posted by Sara Fazio • December 30th, 2011
Pharmacologic thromboprophylaxis has been proven to reduce the incidence of venous thromboembolism in both surgical patients and acutely ill medical patients. In surgical patients, thromboprophylaxis has been shown to reduce the incidence of fatal pulmonary embolism and the rate of death from any cause; in medical patients, studies have shown that thromboprophylaxis is associated with… Read More…